Back to Search
STEVEN BARRIERE, PHARM.D.
PHARM.D.
Pharmacotherapy Pharmacist
NPI: 1508085069Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
RPH28448(CA)
Research & Publications (13)
Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.
PMID 15199073·J Clin Pharmacol·2004
3-trial
Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants.
PMID 19443680·J Clin Pharmacol·2009
3-trial
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures.
PMID 19095213·Am J Surg·2009
4-observational
Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections.
PMID 19025428·Pharmacotherapy·2008
4-observational
Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
PMID 18586659·J Antimicrob Chemother·2008
2-rct
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
PMID 18444791·Clin Infect Dis·2008
3-trial
Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.
PMID 18426898·Antimicrob Agents Chemother·2008
3-trial
Pharmacists and industry: guidelines for ethical interactions.
PMID 18294122·Pharmacotherapy·2008
6-review
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.
PMID 18077636·J Clin Microbiol·2008
8-other
Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.
PMID 17923490·Antimicrob Agents Chemother·2008
3-trial
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.
PMID 16495243·Antimicrob Agents Chemother·2006
3-trial
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
PMID 15889357·Clin Infect Dis·2005
3-trial
Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects.
PMID 15616296·Antimicrob Agents Chemother·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1660 LYON ST
SAN FRANCISCO, CA 94115 - Phone
- (415) 447-8678
Quick Facts
- NPI
- 1508085069
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile